MAY 12, 2020 5:51 AM PDT

Disabling Genes in Immune Cells Prevents Obesity

WRITTEN BY: Tara Fernandez

 

Obesity is a $1.7 trillion problem in the United States, a condition that leads to several chronic illnesses including heart disease, stroke and certain types of cancer. For many, this results in preventable, premature death. Unsurprisingly, identifying clinical strategies to prevent obesity from a pharmacological, or even a genetic standpoint have been in the research spotlight for decades.

Scientists at the Washington University School of Medicine are exploring the possibility of targeting obesity on a genetic level. By switching off a specific gene in immune cells of mice, they successfully stopped mice fed a high-fat diet from becoming obese. The study was published in The Journal of Clinical Investigation.

Obesity and inflammation are intricately linked. The number of macrophages in adipose, or fat tissue, differs depending on an individual’s metabolic status. Lean humans have around 10 percent of macrophages in adipose tissues, while obese people have up to 40 percent. Experts believe that this increased number and activity of macrophages could be linked to metabolic perturbations and the onset of associated chronic diseases in obese individuals.

 

 

By disabling the ASXL2 gene in macrophages, the researchers hypothesized that this would curb chronic low-grade inflammation in fat tissues and in turn, help resist excess weight gain in spite of high-fat diets. Their experimental model involved either genetically modifying macrophages in obese mice, or injecting them with nanoparticles that specifically target and shut off ASXL2.

Interestingly, despite being fed a high calorie diet, the treated mice burnt 45 percent more calories than mice with active macrophage ASXL2.

Principal investigator of the study, Steven L. Teitelbaum, MD, said, “These mice consumed high-fat diets, but they didn’t get fatty livers. They don’t get type 2 diabetes. It seems that limiting the inflammatory effects of their macrophages allows them to burn more fat, which keeps them leaner and healthier.”


Sources: The Journal of Clinical Investigation, Washington University in St. Louis.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
FEB 18, 2021
Immunology
Protective COVID Antibodies Found in Breast Milk
FEB 18, 2021
Protective COVID Antibodies Found in Breast Milk
University of Rochester researchers analyzing breast milk samples from mothers with COVID-19 found that it doesn’t ...
MAR 07, 2021
Genetics & Genomics
Tuberculosis Influenced the Human Genome
MAR 07, 2021
Tuberculosis Influenced the Human Genome
Throughout human history, our species has come into contact with both harmless and infectious microbes that have changed ...
APR 08, 2021
Immunology
What's That Frozen Pizza Doing to Your Immune System?
APR 08, 2021
What's That Frozen Pizza Doing to Your Immune System?
In a recent study, scientists found that commonly-used chemical additives added to processed foods can have toxic effect ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
Loading Comments...